Champix, which launched in the UK in 2006, has previously been linked to heart problems, strokes and blackouts - now experts claim patients taking the anti-smoking pill are more prone to depression, ...
LONDON (MarketWatch) -- Pfizer Inc. said that the U.K. National Institute for Health and Clinical Excellence has recommended its Champix (varenicline) treatment for use on the National Health Service.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback